Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$16.35
0.040.25%
Last update: Apr 24, 2:48 PM
Theravance Biopharma Inc (TBPH) Stock Price, Quote, News & History
TBPHNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Theravance Biopharma (TBPH) stock?
You can purchase shares of Theravance Biopharma (NASDAQ:TBPH) through any online brokerage.
Who are Theravance Biopharma (TBPH) competitors?
Other companies in Theravance Biopharma’s space includes: Zevra Therapeutics Inc (NASDAQ:ZVRA), GH Research PLC (NASDAQ:GHRS), Bioage Labs Inc (NASDAQ:BIOA), Xeris Biopharma Holdings Inc (NASDAQ:XERS) and Phathom Pharmaceuticals Inc (NASDAQ:PHAT).
What is the forecast, or price target, for Theravance Biopharma (TBPH) stock?
Theravance Biopharma has a consensus price target of $17.00.
What is the current price for Theravance Biopharma (TBPH)?
The stock price for Theravance Biopharma (NASDAQ: TBPH) is $16.35 last updated April 24, 2026 at 2:48 PM EDT.
Does Theravance Biopharma (TBPH) pay a dividend?
There are no upcoming dividends for Theravance Biopharma.
When is Theravance Biopharma (NASDAQ:TBPH) reporting earnings?
Theravance Biopharma does not have any upcoming earnings scheduled.
Is Theravance Biopharma (TBPH) going to split?
There is no upcoming split for Theravance Biopharma.
What sector and industry does Theravance Biopharma (TBPH) operate in?
Theravance Biopharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
